LACNETS TeamJan 261 min readBreaking News: NETTER-2 Trial Supports Lutathera® as 1st Line TreatmentThe NETTER-2 phase 3 trial results show Lutathera® may be offered as first-line treatment for newly diagnosed grade 2 and 3 advanced...